Areas of Specialty

 We aim to focus on those difficult cancer patients by expanding expenditure on our R&D studies and also by systemically logging patients' clinical records and forming them into big data. In addition, we are continuing our extensive partnerships with global pharmaceutical companies in clinical experiments, and introducing Korea's first Heavy Ion Therapy System .  It is part of the center's efforts to further focus on incurable cancers, such as pancreatic cancers, esophageal cancer, as well as terminal cancer patients. In order to treat these difficult cases, current clinical treatments have their limits; extensive in-depth research should be preceded.

For that matter, we are focusing on utilizing big data technology to analyze numerous cases of cancer patients. These data will help us to build new arms to treat new patients. The Heavy Ion Therapy System will also contribute greatly in treating cancer patients whose tumors could not be treated with the current X-ray radiation technology. 

Dr. Jinsil Seong

Radiation Oncologist, Yonsei University President, Korean Liver Cancer Association
Professor Seong is one of a few who pioneered radiotherapy of Hepatocellular Carcinoma. She has devoted her entire career on radiotherapy of HCC by practicing, educating and pursuing clinical research. With her enthusiasm and devotion overcoming a minority issue not only in specialty (radiation oncology) but also in gender (women), she has served as a president of the Korean Liver Cancer Association. Additionally, she is the president-elect of the Asia Pacific Primary Liver cancer Expert (APPLE) association, which is a world leading liver cancer association. She also held an annual congress of APPLE 2018 as a congress chairperson.Upon receiving the BFA Dr. Jinsil Seong stated, “I am truly honored and impressed to join world leaders in [the] HCC field who won the award previously. This encourages me to keep going forward for [a] better future of our HCC patients!” 

 Dr. Yongbae Kim is a highly reputed, board-certified Radiation Oncologist, currently working at the Gangnam Severance Hospital. With over two decades of clinical practice under his name, Dr. Yongbae Kim is also affiliated with the distinguished Yonsei University College of Medicine as a Professor of Radiation Oncology.  Dr. Yongbae Kim has the honor of being associated with multiple distinguished organizations such as being a member of the Korea Cancer Association (2002- present), KOSRO (Korean Society of Radiation Oncology) (2003-present)), Korea Breast Cancer Society, and KACO (Korean Association for Clinical Oncology) (2009- present). He also bears the office of the KOSRO, head of research committee for gynecology cancer(2014-present), and is on the Editorial Board, Radiation Oncology Journal from 2015 onwards. Dr. Yongbae Kim also has the distinction of being currently appointed as the Director of General Affairs in KOSRO (2017-present)